The immunohistochemical expression of metallothionein in inflammatory bowel disease. Correlation with HLA-DR antigen expression, lymphocyte subpopulations and proliferation-associated indices

Histology and Histopathology

Volumn 18, Issue 1, 2003, Pages 75-82

  Ioachim, E ^a   Michael, M ^a   Katsanos, C ^a   Demou, A ^a   Tsianos, E V ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

HLA DR antigen; Immunohistochemistry; Inflammatory bowel disease; Ki 67; Lymphocytes subsets; Metallothionein; PCNA

Indexed keywords

ANTIBODY; AVIDIN; AZATHIOPRINE; BIOTIN; CORTICOSTEROID; HLA DR ANTIGEN; KI 67 ANTIGEN; MESALAZINE; METALLOTHIONEIN; METHOTREXATE;

ADULT; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CELL POPULATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; CYTOPLASM; DATA ANALYSIS; ENTERITIS; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE MUCOSA; INTESTINE RESECTION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; PATHOGENESIS; PROTEIN EXPRESSION; REMISSION; SCORING SYSTEM; STAINING; STATISTICAL ANALYSIS; ULCERATIVE COLITIS;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL DIVISION; EPITHELIUM; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; INTESTINE, LARGE; LYMPHOCYTE SUBSETS; MALE; METALLOTHIONEIN; MIDDLE AGED;

EID: 0037217176     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Binder B., Both H., Hansen P.K., Hendriksen C., Kreiner S. and Torp-Pedersen K. (1982). Incidence and prevalence of ulcerative colitis and Crohn's disease in the country of Copenhagen. 1962-1978, Gastroenterology 83, 563-568.
2. Bottazo G.F., Pujol-Borrell R. and Hanafusa T. (1983). Role of aberrant HLA-DR antigen expression and antigen presentation in induction of endocrine autoimmunity. Lancet II, 1115-1117.
3. Bruwer M, Schmid K.W., Metz K.A., Krieglstein C.F., Senninger N. and Schurmann G. (2001). Increased expression of metallothionein in inflammatory bowel disease. Inflamm. Res. 50, 289-293.
4. Chubatsu L.S and Meneghini R. (1993). Metallothionein protects DNA from oxidative damage. Biochem. J. 291, 193-198.
5. Deem R.L., Shanahan F. and Targan S.R. (1991). Triggered human mucosa T cells release tumor necrosis factor-alfa and interferon-gamma which kill human colonic epithelial cells. Clin. Exp. Immunol. 83, 79-84.
6. Douglas-Jones A.G., Havabi H., Morgan J.M. and Jasani B. (1997). Immunoreactive p53 and metallothionein expression in duct carcinoma in situ of the breast. Virchows Arch. 430, 373-379.
7. Elson C.O. (1988). The immunology of inflammatory bowel disease. In: Inflammatory Bowel Disease. 3rd edn. Lea and Febiger. Philadelphia. pp 97-164.
8. Fais S., Pallone F., Squarcia O., Biancone L., Ricci F., Paoluzi P. and Boirivant M. (1987). HLA-DR antigens on colonic epithelial cells in inflammatory bowel disease: I. Relation to the state of activation of lamina propria lymphocytes and to the epithelial expression of other surface markers. Clin. Exp. Immunol. 68, 605-612.
9. Fiocci C. (1992). Cytokines. In: Inflammatory Bowel Disease. MacDermott R.P. and Stenson W. (eds). Elsevier Publishing Co. New York. pp 137-162.
10. Franklin W.R., McDonald G.B., Stein H.O., Gatter K.V., Jewell D.P., Clarke L.C. and Mason D.Y. (1985). Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis. Hum. Pathol. 16, 1129-1132.
11. Fu K., Sarras M.P., De Lisle R.C. and Andrews G.K. (1997). Expression of oxidative stress-responsive genes and cytokine genes during caerulein-induced acute pancreatitis. Am. J. Physiol. 273, 696-705.
12. Fuentealba I.C. and Mullins J.E. (1999). Immunohistochemical demonstration of metallothionein in benign and malignant canine mammary tumours. Histol. Histopathol. 14, 51-61.
13. Fuller C.E., Elmes M.E. and Jasani B. (1990). Age related changes in Metallothionein, copper, copper-associated protein and lipofuscin in human liver: A histochemical and immunohistochemical study. J. Pathol. 161, 167-172.
14. Grishma M.B. and Granger D.N. (1988). Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Dig. Dis. Sci. 33, 6-15S.
15. Hamer D.H. (1986). Metallothionein. Annu. Rev. Biochem. 55, 913-951.
16. Hershberg R.M., Framson P.E., Cho D.H., Lee L.Y., Kovats S., Beitz S. and Blum J.S. (1997). Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. J. Clin. Invest. 100, 204-215.
17. Hidalgo J., Girald M., Garvey J.S. and Armario A. (1988). Physiological role of glycocorticoids on rat serum and liver metallothionein in basal and stress conditions. Am. J. Physiol. 254, E71-78.
18. Hsu S.M., Raine L. and Fanger H. (1981). Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem. 29, 577-580.
19. Hoang P, Crotty B., Dalton H.R. and Jewell D.P. (1992). Epithelial cells bearing class II molecules stimulate allogeneic human colonic intraepithelial lymphocytes. Gut 33, 1089-1093.
20. Kagi J.H.R. (1991). Overview of metallothionein. Methods Enzymol. 205, 613-626.
21. Kappeler A. and Mueller C. (2000). The role of activated cytotoxic T cells in inflammatory bowel disease. Histol. Histopathol. 15, 167-172.
22. Ko H.S., Fu S.M., Winchester R.J., Yu D.T.Y. and Kunkel H.G. (1979). Ia determinants on stimulated human T lymphocytes. J. Exp. Med. 150, 246-255.
23. Lazo J.S. and Pitt B.R. (1995). Metallothioneins and cell death by anticancer drugs. Annu. Rev. Pharmacol. Toxicol. 35, 635-653.
24. Lee H.L. and Archer T.K. (1998). Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter. EMBO J. 17, 1454-1466.
25. Lih-Brody L., Powell S.R., Collier K.P., Reddy G.M., Cerchia R., Kahn E., Weissman G.S., Katz S., Floyd R., McKinley M.J., Fisher S. and Mullin G.E. (1996). Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig. Dis. Sci. 41, 2078-2086.
26. Mahida Y.R., Wu K.C. and Jewell D.P. (1989). Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease. Gut 30, 1362-1370.
27. Masters B.A., Kelly E.J., Quaife C.J., Brinster R.L. and Palmiter R.D. (1994). Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl. Acad. Sci. USA 91, 584-588.
28. Mayer L. and Schlien R. (1987). Evidence for function of Ia molecules on gut epithelial cells in man. J. Exp. Med. 166, 1471-83.
29. McDonald G. and Jewell D.P. (1987). Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory bowel disease. J. Clin. Pathol. 40, 312-317.
30. McKenzie S.J., Baker M.S., Buffinton G.D. and Doe W.F. (1996). Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J. Clin. Invest. 98, 136-141.
31. Mulder T.P., Verspaget H.W., Janssens A.R., De Bruit P.A., Pena A.S. and Lamers C.B. (1991). Decreased in two intestinal/zinc containing proteins with antioxidant function in inflammatory bowel disease. Gut 32, 1146-1150.
32. Mullins J.E. and Fuentealba I.C. (1998). Immunohistochemical detection of metallothionein in liver, duodenum and kidney after dietary copper-overload in rats. Histol. Histopathol. 13, 627-633.
33. Niffsinger A., Unger B. and Fenoglio-Preiser C.M. (1998). Increased cell proliferation characterized Crohn's disease. Mod. Pathol. 11, 1198-1203.
34. Parks D.A. (1989). Oxygen radicals: Mediators of gastrointestinal pathophysiology. Gut 30, 293-298.
35. Powrie F. (1995). T cells in inflammatory bowel disease. Protective and pathogenic roles. Immunity 3, 171-174.
36. Pullman W.E., Elsbury S., Kobayashi M., Hapel A.J. and Doe W.F. (1992). Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology 102, 529-537.
37. Selby W.S., Janossy G., Goldstein G. and Jewell D.P. (1981). T-lymphocyte subsets in human intestinal mucosa: The distribution and relationship to MHC-derived antigens. Clin. Exp. Immunol. 44, 453-458.
38. Selby W.S., Janossy G., Bofill M. and Jewell D.P. (1983). Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin. Exp. Immunol. 1983; 53, 614-618.
39. Shanahan F. and Targan S.R. (1992). Mechanisms of tissue injury in inflammatory bowel disease. In: Current Topics in Gastroenterology-Inflammatory Bowel Disease. McDermott R.P. and Stenson W.F. (eds). Elsevier Science Publishing. New York. pp 77-93.
40. Schwarz M.A., Lazo J.S., Yalowich J.C., Reynolds I., Kagan V.E., Tyurin V., Kim Y.M., Watkins S.C. and Pitt B.R. (1994). Cytoplasmic metallothionein overexpression protects NIH 3T3 cells from tert-butyl hydroperoxide toxicity. J. Biol. Chem. 27, 15238-15243.
41. Schwarz M.A., Lazo J.S., Yalowich J.C., Allen W.P., Whitmore M., Bergonia H.A., Tzeng E., Billiar T.R., Robbins P.D. and Lancaster J.R. (1995). Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. Proc. Natl. Acad. Sci. USA 9, 4452-4456.
42. Sturniolo G.C., Mestriner C., Lecis P.E., D'Odorico A., Venturi C., Irato P., Cecchetto A., Tropea A., Longo G. and D'Inca R. (1998). Altered plasma and mucosal concentrations of trace elements and antioxidants in active ulcerative colitis. Scand. J. Gastroenterol. 33 (6), 644-649.
43. Summer K.H., Klein D., De Ruiter N. and Abel J. (1989). Metallothionein induction by non-steroid anti-inflammatory drugs. Biol. Trace Elem. Res. 21, 165-169.
44. Tamai K.T., Gralla E.B., Ellerby L.M., Valentine J.S. and Thiel D.J. (1993). Yeast and mammalian metallothioneins functionally substitute for yeast copper-zinc superoxide dismutase. Proc. Natl. Acad. Sci. USA. 1, 8013-8017.
45. Todd I., Pujol-Borrell R., Hammond L.J., Bottazzon G.F. and Feldmann M. (1985). Interferon-γ induces HLA-DR expression by thyroid epithelium. Clin. Exp. Immunol. 61, 265-273.
46. Toyoda H., Wang S.-J., Yang H.-Y., Redford A., Magalong D., Tyan D., McElree C.K., Pressman S.R., Shanahan F., Targan S.R. and Rotter J.I. (1993). Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 104, 741-748.
47. Truelove S.C. and Richards W.C.D. (1956). Biopsy studies in ulcerative colitis. Br. Med. J. 1, 1315-1318.
48. Tsianos E.V., Massalas C.N., Merkouropoulos M., Dalekos G.N. and Logan R.F.A. (1994). Incidence of inflammatory bowel disease in North West Greece: Rarity of Crohn's disease in area where ulcerative colitis is common. Gut 35, 369-372.
49. Wakefield A.J., Sawyerr A.M., Dhillon A.P., Pittilo R.M., Rowles P.M. and Lewis A.A.M. (1989). Pathogenesis of Crohn's disease: Multifocal gastrointestinal infraction. Lancet ii, 1057-1062.